Monday, 15 October 2012

Exclusive: MS drug 'rebranded' – at up to 20 times the price

Source The Independent:

A pharmaceutical company stands accused of putting profit before patients after withdrawing a drug used in the treatment of a chronic debilitating disease – ahead of relaunching it at a price predicted to be up to 20 times higher.

Read more here.